Clinical Trials Browser

Enrolling by invitation × tislelizumab × Clear all

NCT07353294 2026-04-22

Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC

Phase 1 Enrolling by invitation

Lymphatic Metastasis

NCT06303583 2024-03-12

CRIS

Phase 1/2 Enrolling by invitation

Gastrointestinal

Esophageal Squamous Cell Carcinoma